Evidence map›Paper›PMID 30296196›Full record

ArticleCancer biology & therapy2019

Iodine-125 seed implantation combined with arterial chemoembolization therapy for pain palliation in metastatic bone cancer: a retrospective study.

Zeran Yang, Guang Chen, Ye Cui, Tianhao Su, Jianan Yu, Guowen Xiao, Yanjing Han, Long Jin

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zeran Yanga Interventional Radiology, Beijing Friendship Hospital , Capital Medical University , Beijing , China.
Guang Chena Interventional Radiology, Beijing Friendship Hospital , Capital Medical University , Beijing , China.
Ye Cuib The Department of Immunology, School of Basic Medical Sciences , Capital Medical University , Beijing , China.
Tianhao Sua Interventional Radiology, Beijing Friendship Hospital , Capital Medical University , Beijing , China.
Jianan Yua Interventional Radiology, Beijing Friendship Hospital , Capital Medical University , Beijing , China.
Guowen Xiaoa Interventional Radiology, Beijing Friendship Hospital , Capital Medical University , Beijing , China.
Yanjing Hana Interventional Radiology, Beijing Friendship Hospital , Capital Medical University , Beijing , China.
Long Jina Interventional Radiology, Beijing Friendship Hospital , Capital Medical University , Beijing , China.
Capital Medical University · CNBeijing Friendship Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone metastases are the most common sites for malignant tumors. Patients who failed to respond to initial first-line treatment with bisphosphonates usually suffer from extreme pain. The aim of this study was to observe the efficacy of arterial chemoembolization combined with Iodine-125 seed implantation in the treatment of bone metastatic cancer pain. All 14 patients with metastatic bone tumor wo failed first-line treatment underwent arterial chemoembolization the day before the implantation of the particles. A computer stereoscopic TPS was used to design the treatment plans, the number and dose of particles required for implantation. Pain relief was evaluated using several parameters such as Visual Analog Scale (VAS) and Verbal Rating Scales (VRS). Pain intensity was measured pre-operation and 1-week, 1-month, 3-month after the treatment. Meanwhile, we also assessed tumor size using computer tomography (CT). Pain palliation was observed in 35.7% (5/14), 57.1% (8/14), and 78.6% (11/14) of all patients at 1-week, 1-month and 3-month post treatment. Likewise, our analysis showed that the combination therapy resulted in a significant decrease of VAS score (6.71 ± 0.49 before treatment vs 3.36 ± 0.40 at 3 month post treatment) and overall responding rate of 92.0% using VRS pain assessment. Consistently, tumor size was reduced from 42.16 ± 10.32 before treatment to 29.11 ± 8.73 at 3 months post treatment. No serious complications were detected. Our study demonstrate that the combination of arterial chemoembolization and

Indexed as

Bone NeoplasmsChemoembolization, TherapeuticFemaleHumansIodine RadioisotopesMaleNeoplasm MetastasisPain ManagementPalliative CareRetrospective StudiesTreatment OutcomeIodine-125Iodine Radioisotopesarterial chemoembolizationbone neoplasmsbrachytherapyIodine-125 seed implantationmetastatic tumor of bonepain reliefretrospective study

Identifiers

PMID30296196
PMCPMC6343693
OpenAlexW2897065830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.